Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000213328 is a human processed pseudogene related to the DCUN1D3 (Defective in cullin neddylation 1 domain containing 3) gene family[4][2][6]. Pseudogenes are generally nonfunctional DNA segments that resemble protein-coding genes but do not encode active proteins due to disabling mutations or the absence of regulatory elements[4]. No evidence supports a protein product, physiological function, involvement in disease, or value as a therapeutic target for this particular pseudogene. It should not be confused with DCUN1D3, a protein-coding gene involved in neddylation of cullin proteins, which is a process relevant to protein degradation regulation via ubiquitin ligases[7][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DCN1, defective in cullin neddylation 1, domain containing 3 pseudogene.